Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O8DI
|
|||
Former ID |
DAP001499
|
|||
Drug Name |
Nitrous oxide
|
|||
Synonyms |
Distickstoffmonoxid; Lachgas; Stickdioxyd; Dinitrogen monoxide; Dinitrogen oxide; Factitious air; Gaz hilarant; Hyponitrous acid anhydride; Laughing gas; Nitrogen hypoxide; Nitrogenium oxydulatum; Nitrous oxide [JAN]; Oxido nitroso; Oxido nitroso [Spanish]; Oxyde nitreux; Stickdioxyd [German]; N2O; Nitrous oxide [UN1070] [Nonflammable gas]; Diazyne 1-oxide; Gas, Laughing; NITROUS-OXIDE; Nitrogen oxide (N2O); Nitrous oxide (TN); Nitrous oxide [Anaesthetics, volatile]; Nitrous oxide, compressed; Nitrous oxide, refrigerated liquid; Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas]; Oxide, Nitrous; Protoxyde d'azote; Protoxyde d'azote [French]; Nitrous oxide (JP15/USP); Oxidodinitrogen(N-N); Stickstoff(I)-oxid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Anxiety disorder [ICD-11: 6B00-6B0Z] | Approved | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
N2O
|
|||
Canonical SMILES |
[N-]=[N+]=O
|
|||
InChI |
1S/N2O/c1-2-3
|
|||
InChIKey |
GQPLMRYTRLFLPF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 10024-97-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
3012, 4143, 4892252, 7626070, 7847170, 7980135, 8144704, 8150883, 10502017, 11528598, 14709699, 15170306, 15218584, 16019504, 24439305, 24845071, 24857798, 48414241, 50475486, 57320613, 76715611, 104250734, 104296324, 125330474, 126673801, 134338688, 134339510, 134990167, 137001256, 137100752, 137124543, 152043101, 162222943, 162232940, 163215012, 163215144, 175268716, 176259895, 223652602, 223975691, 249910823
|
|||
ChEBI ID |
CHEBI:17045
|
|||
ADReCS Drug ID | BADD_D01580 | |||
SuperDrug ATC ID |
N01AX13
|
|||
SuperDrug CAS ID |
cas=010024972
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des. 2006;12(28):3665-79. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.